Market Research Logo

Global Pharmacogenomics Market, by Technology Type, Application and Geography - Trends and Forecast to 2025

Global Pharmacogenomics Market, by Technology Type, Application and Geography - Trends and Forecast to 2025

Pharmacogenomics is an essential research area for development of medication for pain, cancer, psychotropic, and cardiovascular disease. The success of this medication is possible through the use of innovative technologies that help define the dosage setting for subsets of the population and an individual’s response to a specific drug. The success of the precision medicine is possible through the application of pharmacogenomics that uses information about a person’s genes, enzyme activities, cellular environment, and proteins to diagnose and treat diseases. Rapid advancements in groups of specialized molecular diagnostic tests is contributing to the improvement for assessment of real-time treatment of diseases.
Market Dynamics
Major factors that propel the market are increasing demand for personalized drugs, increasing prevalence of several non-infectious and infectious diseases, rising utilization of these technology for effective treatment therapeutics, and growing awareness about benefits associated with pharmacogenomics. Continuous collaboration among pharmacogenomics manufacturers for various applications in clinical and translational research is also expected to drive growth of the market across regions. In 2016, Merck & Co. Inc., collaborated with Biocartis, an innovative molecular diagnostic company to develop and commercialize a new liquid biopsy technology for RAS biomarker testing. This can enable more access to the test for number of metastatic colorectal cancer patients. Furthermore, use of pharmacogenomics to perform diagnostic assays in the field of determining individual’s susceptibility to certain diseases, toxicology, biochemical genetics, and drug safety are also expected to lead to rapid growth of the market for pharmacogenomics over the forecast period.
Key features of the study:

This report provides in-depth analysis of pharmacogenomics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global pharmacogenomics market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans

Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics
The global pharmacogenomics market report caters to various stakeholders in this industry including investors, researchers, pharmacogenomics manufacturers, new entrants, and financial analysts.
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the pharmacogenomics market.

Detailed Segmentation:

Global Pharmacogenomics Market, By Technology Type:

Polymerase Chain Reaction

Sequencing
Microarray
Other Technologies

Global Pharmacogenomics Market, By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Global Pharmacogenomics Market, By Geography:

North America

By Country:

U.S.
Canada

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Asia Pacific

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Latin America

By Country:

Brazil
Mexico
Rest of Latin America

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Africa

By Country:

North Africa
Central Africa
South Africa

By Technology Type:

Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies

By Application:

Drug Discovery
Therapeutic Application

Oncology
Cardiology
Pain Management
Neurological Disorders
Others

Company Profiles

 Thermo Fisher Scientific Inc.*

Company Overview
Technology Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Bayer AG
AstraZeneca plc
Assurex Health
GE Healthcare
Bristol-Myers Squibb Company
Qiagen, Inc.
Hoffmann-La Roche Ltd
Transgenomic, Inc.
Abbott Laboratories, Inc.
GlaxoSmithKline

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Technology Type
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Supply Side Drivers
Demand Side Drivers
Economic Drivers
Restraints
Market Opportunities
Impact Analysis
Epidemiology
Regulatory Scenario
Industry Trends
PEST Analysis
4. Global Pharmacogenomics Market, By Technology Type, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Polymerase Chain Reaction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Sequencing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Microarray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Other Technologies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Pharmacogenomics Market, By Application, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Drug Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Therapeutic Application
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Pharmacogenomics Market, By Regions, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, By Regions, 2017 - 2025
North America
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
GCC Countries
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Bayer AG
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Thermo Fisher Scientific Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
AstraZeneca plc
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Assurex Health
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GE Healthcare
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Bristol-Myers Squibb Company
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Qiagen, Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
F. Hoffmann-La Roche Ltd
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Transgenomic, Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Abbott Laboratories, Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GlaxoSmithKline
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
8. Section
References
Analyst Views
Research Methodology
About Us and Sales Contact
*Browse 29 market data tables and 33 figures on "Pharmacogenomics Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report